Vietnam Pharmaceutical Market Outlook To 2022 - by Generic and Patented drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory)

Vietnam Pharmaceutical Market Outlook To 2022 - by Generic and Patented drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory)


  • Products Id :- KR595
  • |
  • Pages: 56
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

The report titled "Vietnam Pharmaceutical Market Outlook To 2022 - by Generic and Patented drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory)" provides a comprehensive analysis of Vietnam pharmaceutical market overview and size, growth drivers and restraints. The report also provides data points on Vietnam Pharmaceutical market by Generic and Patented drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory and Others) along with company profiles of DHG Pharma, Traphaco, Pymepharco, Ha Tey Pharmaceutical, Mekophar, Domesco, Imexpharma, OPC, Sanofi, GSK, AstraZeneca, Novartis, Roche, Pfizer, MSD and Bayer. The report also covers government regulations, procedure of how drugs procured in public hospitals, Comparative Analysis of Pharmaceutical Companies, Trade scenario, Analyst Recommendations and future outlook for Vietnam Pharmaceutical Market.

Vietnam Pharmaceutical Market Research

Vietnam Pharmaceutical Market Size and Overview
The pharmaceutical market recorded growth at a CAGR of ~% during 2012-2017 increasing from USD ~ billion in 2012 to USD ~ billion in 2017, driven by rise in self-medicating culture and OTC drug sales. Foreign entities are not allowed to engage in distribution activities; hence, they typically conduct marketing activities through representative offices or local drug distributors. Heightened regulatory environment for drug manufacturing has enabled entities which comply with regulatory standards to remain competitive.

Market Segmentation

By Generic and Patented Drugs: Generic drugs dominated the pharmaceutical market with higher revenue share of ~% in the in 2017. Most common generic drugs sold in the market include antibiotics and pain killers. Patented drugs followed generic drugs segment and generated ~% revenue share in 2017. Currently all patented drugs are imported for local consumption. Widely imported patented drugs include high-value specialty drugs for oncology and diabetes management.

By Prescribed Drugs and OTC Drugs: Prescribed drugs dominated the pharmaceutical market with higher revenue share of ~% in the in 2017. Drugs prescribed by clinicians mostly consisted of imported and patented drugs. OTC drugs followed prescribed drugs segment and generated ~% revenue share in 2017. Sales of OTC drugs have been on an incline owing to rise in trend of self-medication in Vietnam. About 88-91% of antibiotics are sold via OTC channel.

By Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory and Others): Metabolism and Nutritional Medicine dominated the therapeutic drugs in pharmaceutical market with highest revenue share of ~% in the in 2017. Pharmaceutical market has witnessed high demand for nutritional and metabolism health supplements especially for segments including skin care, anti-aging, eye health and digestive health. Antibiotic consumption has risen steeply in the last few years. Recent statistics reveal that about ~% to ~% of all antibiotics were sold without prescription in Vietnam. Others include contraception, gastrointestinal, skin, allergy, endocrine, analgesic and contributed ~% revenue share in the therapeutic drugs in the pharmaceutical market.

Future Outlook to Vietnam Pharmaceutical Market
The pharmaceutical market is expected to record growth at a CAGR of ~% during 2017-2022, driven by rise in utilization of generic drugs, especially those manufactured locally. Generic drug usage will continue to rise in future owing to rising number of drug manufacturers and government’s push for production and utilization of locally produced. Prescribed drugs will dominate the pharmaceutical market but there will be increase in the OTC medication due to self medication. Antibiotics, Vitamins and dietary supplements will continue to attract heavy demand through OTC channel. Demand for oncology drugs and system infections medicine is expected to become almost ~ times the size in 2017 with revenue contribution of USD ~ million and USD ~ million in 2022. Respiratory drugs are anticipated to register highest CAGR of ~% to reach USD ~ million by 2022.
Key Topics Covered in the Report

  • Vietnam Pharmaceutical Market Overview and Size
  • Vietnam Pharmaceutical Market Growth drivers
  • Vietnam Pharmaceutical Market Restraints
  • Vietnam Pharmaceutical Market by Generic and Patented drugs
  • Vietnam Pharmaceutical Market by Prescribed Drugs and OTC Drugs
  • Vietnam Pharmaceutical Market by Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory and Others)
  • Government regulations
  • Procedure of how drugs procured in public hospitals
  • Comparative Analysis of Pharmaceutical Companies
  • Trade scenario (Import and Export)
  • Analyst Recommendations for Vietnam Pharmaceutical Market
  • Future outlook for Vietnam Pharmaceutical Market


Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1. Research Methodology
1.1: Market Definitions
1.2: Abbreviations
1.3: Consolidated Research Approach
1.4: Market Sizing and Limitations
1.5: Products and Test Covered
1.6: Variables (Dependent and Independent)
1.7: Correlation Matrix
1.8: Regression Matrix
Healthcare Scenario
2.1: Healthcare Ecosystem
2.2: How are Healthcare Organizations Positioned
2.3: Vietnam Healthcare Metrics
2.4: Health Statistics
2.5: Vietnam Universal Health Coverage
Vietnam Healthcare Market
3.1: Vietnam Healthcare Market Size by Revenues
3.2: Vietnam Healthcare Market Segmentation by Healthcare Sectors, 2012 & 2017
3.3: Vietnam Healthcare Market Future Outlook and Projections, 2018-2022
Vietnam Pharmaceuticals Market
4.1: Executive Summary
4.2: Vietnam Pharmaceuticals Market Overview
4.3: Vietnam Pharmaceuticals Market Size by Revenues, 2012-2017
4.4: Growth Drivers in Vietnam Pharmaceuticals Market
4.5: Restraints in Vietnam Pharmaceuticals Market
4.6: Market Segmentation for Vietnam Pharmaceuticals Market by Generic and Patented Drugs, 2013 and 2017
4.7: Market Segmentation for Vietnam Pharmaceuticals Market by Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory), 2013 and 2017
4.8: Government Regulations for The Launch of New Drugs
4.9: How are Drugs Procured by Public Hospitals?
Comparative Analysis of Major Pharmaceutical Companies in Vietnam
4.10: Trade Scenario of Pharmaceutical Market in Vietnam (Imports and Exports), 2012-2017 4.11: Vietnam Pharmaceuticals Market Future Outlook and Projections, 2018-2022
4.12: Analyst Recommendations
Disclaimer

License Type Excel Only Single User Single User + Excel Hard Copy Corporate User License
User Sharing Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Access to Printed Report; No Soft Copy Multiple Users within the Company/ Enterprise
Print Option
Copy Option :Yes :No
Citation Yes (Not Publically; but to Private Parties within the company/ affiliate)
Deliverable Format :via Email :via Email ; :via Email Printed Publication/ Book by Post ; :via Email
Customization 20%
Analyst Time (Post Purchase Queries on Call/ Email)
Disclaimer : In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.
To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

DHG Pharma, Traphaco, Pymepharco, Ha Tey Pharmaceutical, Mekophar, Domesco, Imexpharma, OPC, Sanofi, GSK, AstraZeneca, Novartis, Roche, Pfizer, MSD and Bayer

Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory, Generic, Patented drugs, Prescribed Drugs, OTC Drugs, Medicine Consumed, Medicine Imported

select a license
Single User License
USD 2000 INR 137240
Hard Copy License
USD 3000 INR 205860
Corporate User License
USD 4000 INR 274480

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com